These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 30478168)
21. Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration. Imberti R; Cusato M; Villani P; Carnevale L; Iotti GA; Langer M; Regazzi M Chest; 2010 Dec; 138(6):1333-9. PubMed ID: 20558557 [TBL] [Abstract][Full Text] [Related]
22. Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients. Roger C; Wallis SC; Louart B; Lefrant JY; Lipman J; Muller L; Roberts JA J Antimicrob Chemother; 2016 Jun; 71(6):1643-50. PubMed ID: 26957490 [TBL] [Abstract][Full Text] [Related]
35. Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy. Kalaria S; Williford S; Guo D; Shu Y; Medlin C; Li M; Yeung SYA; Ali F; Jean W; Gopalakrishnan M; Heavner M Pharmacotherapy; 2021 Feb; 41(2):205-211. PubMed ID: 33438291 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy. Awissi DK; Beauchamp A; Hébert E; Lavigne V; Munoz DL; Lebrun G; Savoie M; Fagnan M; Amyot J; Tétreault N; Robitaille R; Varin F; Lavallée C; Pichette V; Leblanc M Pharmacotherapy; 2015 Jun; 35(6):600-7. PubMed ID: 26095008 [TBL] [Abstract][Full Text] [Related]
37. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients. Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309 [TBL] [Abstract][Full Text] [Related]
38. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii. Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664 [TBL] [Abstract][Full Text] [Related]
39. Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients. Boisson M; Jacobs M; Grégoire N; Gobin P; Marchand S; Couet W; Mimoz O Antimicrob Agents Chemother; 2014 Dec; 58(12):7331-9. PubMed ID: 25267660 [TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria. Kristoffersson AN; Rognås V; Brill MJE; Dishon-Benattar Y; Durante-Mangoni E; Daitch V; Skiada A; Lellouche J; Nutman A; Kotsaki A; Andini R; Eliakim-Raz N; Bitterman R; Antoniadou A; Karlsson MO; Theuretzbacher U; Leibovici L; Daikos GL; Mouton JW; Carmeli Y; Paul M; Friberg LE Clin Microbiol Infect; 2020 Dec; 26(12):1644-1650. PubMed ID: 32213316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]